IPOPLUS

₹2,361.1

▼ -52.5 -2.18%

12 Jun 2026

NSE Listed

Kwality Pharmaceuticals (KPL)

Volume: 39,791Avg Vol 1W: 60,640.4Avg Vol 1M: 75,617.9552W Range:₹1,561₹2,600
NSE BSE
₹2,361.1▼ 2.18%
Key Ratios
Updated 3h ago
Market Cap—
Current Price₹2,361.1
Previous Close₹2,413.6
High / Low (52w)₹2,600 / ₹1,561
Volume39,791
Avg Vol (1W)60,640.4
Avg Vol (1M)75,617.95
Stock P/E22.63
Book Value₹319.46
Dividend Yield—
ROE16.4%
ROA—
Revenue (TTM)₹372 Cr
Revenue Growth—
Profit Margin—
Total Debt₹15 Cr
Shares Outstanding—
Face Value₹10
EPS (TTM)₹24.39
P/B3.43
Debt / Equity0.43
50 DMA₹1,952.46
200 DMA₹1,952.46
Day change-2.18%
Price Chart
₹2,361.1▲ 42.01% · 1Y
₹2507₹15804.6L
2026-04-20
2026-06-12

20-day avg volume: 76K shares

Pros
  • Healthy return on equity of 16.4%.
  • Company is almost debt-free.
Cons
  • Revenue fell 46% YoY.
Quarterly Results
MetricJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue₹80 Cr₹90 Cr₹84 Cr₹116 Cr₹111 Cr₹111 Cr₹123 Cr₹157 Cr
EBITDA₹14 Cr₹15 Cr₹14 Cr₹22 Cr₹20 Cr₹21 Cr₹26 Cr₹35 Cr
Net Profit₹8 Cr₹8 Cr₹9 Cr₹14 Cr₹12 Cr₹14 Cr₹16 Cr₹25 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹143 Cr₹264 Cr₹460 Cr₹254 Cr₹309 Cr₹372 Cr
EBITDA₹13 Cr₹24 Cr₹164 Cr₹48 Cr₹49 Cr₹64 Cr
Net Profit₹8 Cr₹15 Cr₹120 Cr₹19 Cr₹24 Cr₹40 Cr
EPS——————
Balance Sheet
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹133 Cr₹166 Cr₹341 Cr₹354 Cr₹394 Cr₹447 Cr
Total Liabilities₹88 Cr₹106 Cr₹161 Cr₹155 Cr₹172 Cr₹185 Cr
Equity₹45 Cr₹60 Cr₹180 Cr₹199 Cr₹223 Cr₹262 Cr
Total Debt₹10 Cr₹18 Cr₹20 Cr₹27 Cr₹20 Cr₹15 Cr
Cash Flow
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹9 Cr₹33 Cr₹102 Cr₹48 Cr₹44 Cr₹69 Cr
Investing₹-18 Cr₹-23 Cr₹-63 Cr₹-48 Cr₹-26 Cr₹-29 Cr
Financing₹12 Cr₹1 Cr₹6 Cr₹1 Cr₹-17 Cr₹-14 Cr
Free Cash Flow₹9 Cr₹33 Cr₹102 Cr₹48 Cr₹44 Cr₹69 Cr

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search